Literature DB >> 24165989

[Management of peripheral vascular disease based on current guidelines. Peripheral artery occlusive disease of the iliac and femoral arteries and carotid artery stenosis].

M T Grebe1, R Sternitzky.   

Abstract

The article summarizes the recommendations of current European and American guidelines concerning the diagnosis and treatment of peripheral arterial occlusive disease and carotid artery stenosis. In comparison to older recommendations, current guidelines concerning endovascular treatment and concomitant medical therapy have been changed in recent years. With the exception of very complex and long lesions, endovascular methods are seen as the therapy of choice for revascularization of the iliac and femoral arteries. For cardiovascular risk reduction, patients with symptomatic peripheral arterial disease and stenosis of the carotid arteries should receive antiplatelet as well as statin therapy and should not be treated different from patients with coronary artery disease.

Entities:  

Mesh:

Year:  2013        PMID: 24165989     DOI: 10.1007/s00059-013-3985-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  51 in total

Review 1.  Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication.

Authors:  B L W Bendermacher; E M Willigendael; J A W Teijink; M H Prins
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

3.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

4.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

5.  Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis.

Authors:  J David Spence; Victoria Coates; Hector Li; Arturo Tamayo; Claudio Muñoz; Daniel G Hackam; Maria DiCicco; Janine DesRoches; Chrysi Bogiatzi; Jonathan Klein; Joaquim Madrenas; Robert A Hegele
Journal:  Arch Neurol       Date:  2009-12-14

6.  Prevalence of peripheral arterial disease: persistence of excess risk in former smokers.

Authors:  Bess Fowler; Konrad Jamrozik; Paul Norman; Yvonne Allen
Journal:  Aust N Z J Public Health       Date:  2002       Impact factor: 2.939

7.  The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects.

Authors:  Victor Aboyans; Elena Ho; Julie O Denenberg; Lindsey A Ho; Loki Natarajan; Michael H Criqui
Journal:  J Vasc Surg       Date:  2008-08-09       Impact factor: 4.268

8.  Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication.

Authors:  F B Smith; G D Lowe; A J Lee; A Rumley; G C Leng; F G Fowkes
Journal:  J Vasc Surg       Date:  1998-07       Impact factor: 4.268

9.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.

Authors:  A Halliday; A Mansfield; J Marro; C Peto; R Peto; J Potter; D Thomas
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

10.  ROC analysis of noninvasive tests for peripheral arterial disease.

Authors:  J G Lijmer; M G Hunink; J J van den Dungen; J Loonstra; A J Smit
Journal:  Ultrasound Med Biol       Date:  1996       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.